A recent article in Woman’s Day provides valuable insight into how to reach out to someone when you learn they have been diagnosed with cancer. Here's a list of ten things you should never say to a cancer patient.
The European Commission recently announced that Stivarga (regorafenib) from Bayer has been approved in the European Union (EU) as a third line treatment for GIST.
Lancet Oncology, a comprehensive overview of known or suspected drug-drug interactions between tyrosine-kinase inhibitors (Gleevec, Sutent, Stivarga) prescribed for GIST.
Dr. Janet Woodcock, director of the Center for Drug Evaluation and Research spoke to the House of Representatives about patient perspective.
Patient advocacy is a vital component in assuring that roadblocks to optimal treatment do not prevent cancer patients from obtaining the help they deserve. Recently, a group from Parent Project Muscular Dystrophy presented the FDA [...]
Personalized or targeted medicine is the paradigm of the future: treatment options customized for individual patients.
A recent article from FierceBiotech announced that theAnti-PD-1 cancer drug nivolumab, a fully human antibody, received regulatory approval in Japan.
Marshall Summar, MD to testify on behalf of NORD at 21st Century Cures Hearing in Washington, D. C. on Friday, July 11 at 9 AM ET.
Coverage of GIST Awareness Day continues with this press release that calls attention to our awareness campaign and our support for the global GIST community.
As the cost of cancer treatment rises, so does the anxiety level of those diagnosed. The University of Chicago has developed a tool to assess the financial pain of cancer treatment. In the July issue of [...]
